Gabin, Carlo O.

HRN: 09-74-74  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/10/2026
08/17/2026
IV
500mg
Q8
Hernia Indirect Right Irreducible
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominalProphylaxis    Compliance to guidelines: Compliant To Guidelines